Back to ASND
CITADEL ADVISORS LLC ASND Position History
Ascendis Pharma A/S • Healthcare
Quarters held
60
Latest value
$24.8M
Q2 2026
Peak value
$175.4M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $5.7M |
| Q1 2023 | $1.1M |
| Q1 2023 | $1.6M |
| Q1 2023 | $11.3M |
| Q2 2023 | $1.2M |
| Q2 2023 | $4.6M |
| Q2 2023 | $1.6M |
| Q2 2023 | $1.2M |
| Q3 2023 | $1.8M |
| Q3 2023 | $1.3M |
| Q3 2023 | $23K |
| Q4 2023 | $2.9M |
| Q4 2023 | $642K |
| Q4 2023 | $9.7M |
| Q4 2023 | $11.9M |
| Q4 2023 | $2.8M |
| Q1 2024 | $2.3M |
| Q1 2024 | $1.2M |
| Q1 2024 | $69.2M |
| Q1 2024 | $29.9M |
| Q2 2024 | $4.4M |
| Q2 2024 | $1.1M |
| Q2 2024 | $64.7M |
| Q2 2024 | $8.6M |
| Q2 2024 | $1.1M |
| Q3 2024 | $3M |
| Q3 2024 | $4M |
| Q3 2024 | $82.5M |
| Q3 2024 | $16.7M |
| Q4 2024 | $1.7M |
| Q4 2024 | $1.7M |
| Q4 2024 | $122.6M |
| Q4 2024 | $750K |
| Q1 2025 | $4.5M |
| Q1 2025 | $1.1M |
| Q1 2025 | $175.4M |
| Q1 2025 | $14K |
| Q1 2025 | $393K |
| Q2 2025 | $101.4M |
| Q2 2025 | $3.4M |
| Q2 2025 | $12K |
| Q2 2025 | $690K |
| Q3 2025 | $1.8M |
| Q3 2025 | $18.6M |
| Q3 2025 | $3.7M |
| Q3 2025 | $1.7M |
| Q4 2025 | $106M |
| Q4 2025 | $12.9M |
| Q4 2025 | $4.8M |
| Q4 2025 | $4M |
| Q1 2026 | $13.2M |
| Q1 2026 | $2.3M |
| Q2 2026 | $33.4M |
| Q2 2026 | $46.9M |
| Q2 2026 | $3.3M |
| Q2 2026 | $24.8M |
| Q2 2026 | $33.4M |
| Q2 2026 | $46.9M |
| Q2 2026 | $3.3M |
| Q2 2026 | $24.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $24.8M | 93.1K | — | — |
| Q2 2026 | $3.3M | 12.5K | — | — |
| Q2 2026 | $46.9M | 175.8K | — | — |
| Q2 2026 | $33.4M | 125.4K | — | — |
| Q2 2026 | $24.8M | 93.1K | — | — |
| Q2 2026 | $3.3M | 12.5K | — | — |
| Q2 2026 | $46.9M | 175.8K | — | — |
| Q2 2026 | $33.4M | 125.4K | — | — |
| Q1 2026 | $2.3M | 10.0K | — | — |
| Q1 2026 | $13.2M | 57.6K | — | — |
| Q4 2025 | $4M | 18.7K | — | — |
| Q4 2025 | $4.8M | 22.6K | — | — |
| Q4 2025 | $12.9M | 60.7K | — | — |
| Q4 2025 | $106M | 496.9K | — | — |
| Q3 2025 | $1.7M | 8.4K | — | — |
| Q3 2025 | $3.7M | 18.7K | — | — |
| Q3 2025 | $18.6M | 93.8K | — | — |
| Q3 2025 | $1.8M | 9.0K | — | — |
| Q2 2025 | $690K | 4.0K | — | — |
| Q2 2025 | $12K | 72 | — | — |
| Q2 2025 | $3.4M | 19.7K | — | — |
| Q2 2025 | $101.4M | 587.3K | — | — |
| Q1 2025 | $393K | 331.0K | — | — |
| Q1 2025 | $14K | 89 | — | — |
| Q1 2025 | $175.4M | 1.13M | — | — |
| Q1 2025 | $1.1M | 6.8K | — | — |
| Q1 2025 | $4.5M | 29.1K | — | — |
| Q4 2024 | $750K | 5.5K | — | — |
| Q4 2024 | $122.6M | 890.5K | — | — |
| Q4 2024 | $1.7M | 12.7K | — | — |
| Q4 2024 | $1.7M | 12.1K | — | — |
| Q3 2024 | $16.7M | 111.5K | — | — |
| Q3 2024 | $82.5M | 552.4K | — | — |
| Q3 2024 | $4M | 26.7K | — | — |
| Q3 2024 | $3M | 19.8K | — | — |
| Q2 2024 | $1.1M | 1.00M | — | — |
| Q2 2024 | $8.6M | 63.0K | — | — |
| Q2 2024 | $64.7M | 474.8K | — | — |
| Q2 2024 | $1.1M | 7.7K | — | — |
| Q2 2024 | $4.4M | 32.6K | — | — |
| Q1 2024 | $29.9M | 25.80M | — | — |
| Q1 2024 | $69.2M | 457.5K | — | — |
| Q1 2024 | $1.2M | 7.9K | — | — |
| Q1 2024 | $2.3M | 15.4K | — | — |
| Q4 2023 | $2.8M | 2.75M | — | — |
| Q4 2023 | $11.9M | 94.9K | — | — |
| Q4 2023 | $9.7M | 76.7K | — | — |
| Q4 2023 | $642K | 5.1K | — | — |
| Q4 2023 | $2.9M | 23.4K | — | — |
| Q3 2023 | $23K | 248 | — | — |
| Q3 2023 | $1.3M | 14.3K | — | — |
| Q3 2023 | $1.8M | 18.7K | — | — |
| Q2 2023 | $1.2M | 14.0K | — | — |
| Q2 2023 | $1.6M | 18.4K | — | — |
| Q2 2023 | $4.6M | 51.2K | — | — |
| Q2 2023 | $1.2M | 12.9K | — | — |
| Q1 2023 | $11.3M | 105.9K | — | — |
| Q1 2023 | $1.6M | 15.1K | — | — |
| Q1 2023 | $1.1M | 10.1K | — | — |
| Q1 2023 | $5.7M | 52.8K | — | — |
Other funds holding ASND
$290.4M
$137.1M
$137.1M